English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Moomoo AI Jan 2, 2024 09:19

Investors currently view BGI Genomics as an underperforming ...

Investors currently view BGI Genomics as an underperforming company, largely influenced by its poor revenue growth over the past years. Its P/S ratio may tumble further if the company fails to improve its revenue growth, leading to further investor disappointment.
Improved Revenues Required Before BGI Genomics Co., Ltd. (SZSE:300676) Shares Find Their Feet
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
Translate
Report
4471 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4730
    Followers
    0
    Following
    10K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartLatest Price
    NVDA
    NVIDIA
    -- 131.760
    TSLA
    Tesla
    -- 396.360
    RGTI
    Rigetti Computing
    -- 8.9500
    AMD
    Advanced Micro Devices
    -- 116.090
    PLTR
    Palantir
    -- 65.910
    News
    Trump's Inauguration 2025: Tradition, Corporate Support, and Market Implications for the First 100 Days
    Jan 17 14:13
    What to Expect in the Week Ahead (NFLX Earnings and Trump inauguration)
    19 mins ago
    TikTok Not Available in Google App Store, Tiktok.com No Longer Showing Videos
    11:56
    Coming Up Live: Donald Trump's 2025 Inauguration
    Jan 15 11:47
    Trump Launches Surprise Meme Coin Just Before Inauguration and Price Soars
    11:31
    Discussing
    Trump 2.0 countdown: What's the next big opportunity in the markets?
    🎙️️ Discussion: 1. Could Trump's cryptocurrency policies potentially benefit the crypto market? 2. Might his tariff policies have a positiv Show More
    Trump 2.0 Opportunity Preview: Guess the market winner before the president takes office!